Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 105, pseudogene (RNU1-105P) is a human pseudogene corresponding to a U1 small nuclear RNA (snRNA) gene family member[1][4][6]. Pseudogenes such as RNU1-105P are derived from genes that encode functional RNAs but have accumulated mutations rendering them non-functional; thus, this locus does not yield a functional snRNA involved in spliceosomal activity. RNU1-105P lacks the biological activity of canonical U1 snRNA, which normally plays a role in pre-mRNA splicing as a component of the spliceosome. There are no known therapeutic interventions, disease associations, or use as a biomarker or drug target related to RNU1-105P[1][4][6]. **Clarification:** RNU1-105P is a *pseudogene*, not a protein-coding gene, not a receptor, and not a therapeutic target. Pseudogenes are generally *not* targets for drugs, do not have direct biological functions themselves, and are not involved as disease markers unless specified otherwise in the literature, which is not the case for RNU1-105P per available data[1][4][6]. **Summary of issues:** - RNU1-105P is not a true molecular target (e.g., receptor, enzyme, transporter); it is a non-coding RNA pseudogene[1][4][6]. - There is no evidence it has any therapeutic relevance, biological function, disease association, or drug interaction. - It should not be used as a canonical therapeutic target entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 105, pseudogene (RNU1-105P).